IGL Information

Institut Georges Lopez (IGL) develops innovative solutions for organ preservation and perfusion supporting transplantation worldwide. Organ transplantation saves lives, yet the number of transplantable organs remains limited. IGL’s mission is to support transplant teams in expanding the pool of viable organs and improving graft outcomes. Through advanced preservation solutions and machine perfusion technologies, IGL combines scientific expertise, research and industrial know-how to maintain organ viability from donation to transplantation. Our products are regulated as drugs and medical devices and are developed in close collaboration with the medical community. Headquartered in the Greater Lyon area in France and part of the I-CAIR Group, IGL operates through a network of subsidiaries in France, Italy, the United States and Brazil, allowing us to remain close to transplant centers and healthcare professionals worldwide. New Chances Matter.